地高辛注射液联合倍他乐克治疗充血性心力衰竭伴快速房颤的临床效果  

Therapeutic Effect of Digoxin Injection combined with Betalucil in Treating Patients with Congestive Heart Failure and Rapid Atrial Fibrillation

作　　者：刘金涛[1] Liu Jintao(Beijing Changping District Hospital of Integrative Medicine,Beijing 102208,China)

机构地区：[1]北京市昌平区中西医结合医院,北京102208

出　　处：《中外医药研究》2023年第25期33-35,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH

摘　　要：目的:探讨地高辛注射液联合倍他乐克治疗充血性心力衰竭伴快速房颤的临床效果。方法:选取2021年1月—2022年1月北京市昌平区中西医结合医院收治的80例充血性心力衰竭伴快速房颤患者,采用随机分配的方式分为对照组和观察组,各40例。对照组应用地高辛注射液治疗,观察组在对照组基础上联合应用倍他乐克治疗。比较两组患者的治疗效果。结果:观察组患者治疗总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗后心率明显低于治疗前,左室射血分数明显高于治疗前,且观察组心率低于对照组,左室射血分数高于对照组,差异有统计学意义(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:针对充血性心力衰竭伴快速房颤患者采用地高辛注射液联合倍他乐克治疗,可以有效改善患者心功能,提高治疗效果,且安全性高,具有一定推广价值。Objective:To explore the therapeutic effect of digoxin injection combined with betalactam in the patients with congestive heart failure and rapid atrial fibrillation.Methods:80 patients with congestive heart failure and rapid atrial fibrillation admitted to the Combined Hospital of Traditional Chinese and Western Medicine in Changping District,Beijing,China,from January 2021 to January 2022 were selected to the study and divided into the control group and the observation group,each with 40 cases,by random allocation.The control group was treated with digoxin injection,and the observation group was treated with betalactam on the basis of the control group.The clinical effects of the two groups were compared.Results:The total effective rate of treatment of patients in the observation group was higher than in the control group,and the difference was statistically significant(P<0.05).The heart rate of the two groups of patients after treatment was significantly lower than that before treatment,and the left ventricular ejection fraction was significantly higher than that before treatment,and the heart rate of the observation group was lower than that of the control group,and the left ejection fraction was higher than that of the control group,and the difference was statistically significant(P<0.05).The difference in the incidence of adverse reactions between the two groups was not statistically significant(P>0.05).Conclusion:Digoxin injection combined with betalactam can effectively improve the cardiac function and therapeutic effect of patients with congestive heart failure and rapid atrial fibrillation,and it is safe,so it has a certain value of popularization.

关 键 词：充血性心力衰竭 快速房颤 地高辛注射液 倍他乐克 

分 类 号：R54[医药卫生—心血管疾病]